Rivaroxaban attenuates thrombosis by targeting the NF-κB signaling pathway in a rat model of deep venous thrombus

Anticoagulant therapy is commonly used for the prevention and treatment of patients with deep venous thrombus. Evidence has shown that rivaroxaban is a potential oral anticoagulant drug for the acute treatment of venous thromboembolism. However, the rivaroxaban-mediated molecular mechanism involved...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Junhao, Li, Xinxi, Wang, Yang, Yang, Zhenwei, Luo, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716436/
https://www.ncbi.nlm.nih.gov/pubmed/29039441
http://dx.doi.org/10.3892/ijmm.2017.3166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716436/
https://www.ncbi.nlm.nih.gov/pubmed/29039441
http://dx.doi.org/10.3892/ijmm.2017.3166

Ejemplares similares